06-13-2018 04:47 PM CET - Business, Economy, Finances, Banking & Insurance
Print

Metagenomic Sequencing Market, Global Key players-GATC Biotech AG (Germany), Enterome Bioscience (France), Illumina Inc. (U.S.), Aperiomics, Inc. (U.S.), The Mitre Corporation (U.S.), F Hoffman-La Roche Ltd. (Switzerland) during 2017 to 2023

Press release from: Market Research Future
PR Agency: Market Research Future
Metagenomic Sequencing Market
Metagenomic Sequencing Market


Market Scenario:

Metagenomics sequencing is also known as environmental or community genomics. It is termed as the genomic study wherein the DNA of the specified host microorganism is extracted and cloned directly from the microorganism. Genetic testing is an expensive affair. Moreover, the testing requires specific infrastructure and resources. Currently, the genetic testing market is majorly spread in North American and West European region. There are huge opportunities for the service providers and companies to make the tests affordable and enter the untapped regions of the world with a great scope of expanding. The reducing costs of the tests may also encourage people to undergo the genetic tests.

The rising awareness of genetic disorders drives the global metagenomic sequencing market among the population. The advanced technological platforms and improved genomic tools are the key factors driving the growth of the global metagenomic sequencing market during the forecast period.

Get Sample Copy @ www.marketresearchfuture.com/sample_request/5598

Furthermore, the factors such as the use of advanced bioinformatics tools, recovery of novel drugs, high throughput screening (HTS) methods, and the development of cost-effective technologies such as next-generation sequencing (NGS) are driving the market growth. Moreover, rising R&D activities to identify new antibiotics and enzymes, and improved bioinformatics offers some attractive opportunities to the key market players. Growing concerns regarding the standardization and accuracy of diagnostic testing, lack of skilled professionals, and lack of knowledge is likely to restrain the market growth over the forecast period.

The global metagenomic sequencing market is expected to grow at a CAGR of approximately 6.5% during the forecast period 2017-2023.

Intended Audience

Metagenomic Sequencing Test Kit Suppliers
Metagenomic Sequencing Test Kit Manufacturers
Research and Development (R&D) Companies
Medical Research Laboratories
Academic Medical Institutes and Universities
Segmentation

The global metagenomic sequencing market is segmented on the basis of technology, application, and end user.

On the basis of the technology, the global metagenomic sequencing market is segmented into sequencing, bioinformatics, and others

On the basis of the application, the global metagenomic sequencing market is segmented into infectious disease diagnosis, environmental remediation, gut microbe characterization, biotechnology, biofuel, ecology, agriculture, and others

On the basis of the end user, the global metagenomic sequencing market is segmented into hospitals, research institutes, specialized clinics, and others.

Report with Discount Available @ www.marketresearchfuture.com/check-discount/5598

TABLE OF CONTENT

Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers
4.2 Restrains

4.3 Opportunities
4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers

5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry

Read Comprehensive Overview of Report @ www.marketresearchfuture.com/reports/metagenomic-sequenci...

Key Players

Some of key the players in the global metagenomic sequencing market are GATC Biotech AG (Germany), Enterome Bioscience (France), Illumina Inc. (U.S.), Aperiomics, Inc. (U.S.), The Mitre Corporation (U.S.), F Hoffman-La Roche Ltd. (Switzerland), SciGenom Labs Pvt. Ltd. (India), Second Genome Therapeutics (U.S.), Quest Diagnostics Incorporated (U.S.), Freenome Inc. (U.S.), GenapSys, Inc. (U.S.), COSMOSID (U.S.), Pacific Biosciences (U.S.), Beijing Genomics Institute (China), Biomatters Ltd. (New Zealand), Thermo Fisher Scientific Inc. (U.S.), Oxford Nanopore Technologies Inc. (UK), CLC Bio (Qiagen) (Denmark), Agilent Technologies Inc. (U.S.), DNAStar Inc. (U.S.), Macrogen Inc. (South Korea), Helicos BioSciences (U.S.), Knome Inc. (U.S.), and others.

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India

This release was published on openPR.
News-ID: 1081352 • Views: 620
More releasesMore releases

You can edit or delete your press release here: